Non-genetic factors and polymorphisms in genes CYP2C9 and VKORC1: predictive algorithms for TTR in Brazilian patients on warfarin

被引：0
|
作者：
Marcus Fernando S. Praxedes
Maria Auxiliadora P. Martins
Aline O. M. Mourão
Karina B. Gomes
Edna A. Reis
Renan P. Souza
Emílio Itamar F. Campos
Daniel D. Ribeiro
Manoel Otávio C. Rocha
机构：
[1] Universidade Federal de Minas Gerais,Faculdade de Farmácia
[2] Universidade Federal do Recôncavo da Bahia,Centro de Ciências da Saúde
[3] Universidade Federal de Minas Gerais,Faculdade de Medicina
[4] Universidade Federal de Minas Gerais,Hospital das Clínicas
[5] Universidade Federal de Minas Gerais,Instituto de Ciências Biológicas
来源：
European Journal of Clinical Pharmacology | 2020年 / 76卷
关键词：
Algorithms; Warfarin; Cytochrome P-450 ; protein; Quality of health care;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：199 / 209
页数：10
相关论文
共 50 条
  • [31] Influence of CYP2C9 and VKORC1 Polymorphisms on Warfarin and Acenocoumarol in a Sample of Lebanese People
    Esmerian, Maria O.
    Mitri, Zahi
    Habbal, Mohammad-Zuheir
    Geryess, Eddy
    Zaatari, Ghazi
    Alam, Samir
    Skouri, Hadi N.
    Mahfouz, Rami A.
    Taher, Ali
    Zgheib, Nathalie K.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (10): : 1418 - 1428
  • [32] Role of CYP2C9 and VKORC1 Polymorphisms in Patients With Hypersensitivity to Acenocoumarol
    Outeda-Macias, M.
    Salvador-Garrido, P.
    Martinez-Lopez, L. M.
    Sanchez-Parada, L.
    Martin-Herranz, I
    THERAPEUTIC DRUG MONITORING, 2013, 35 (05) : 712 - 712
  • [33] Effect of VKORC1 and CYP2C9 polymorphisms on warfarin dose requirement in Bangladeshi population
    Chowdhury, Zahid Sadek
    Shahjin, Farah
    Akter, Farhana
    Ahmed, Maizbha Uddin
    Islam, Mohammad Safiqul
    Bin Sayeed, Muhammad Shandaat
    Islam, Reazul
    Hasnat, Abul
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 30 (02) : 341 - 346
  • [34] Correction to: The Influence of CYP2C9 and VKORC1 Gene Polymorphisms on the Response to Warfarin in Egyptians
    Ahmed M. L. Bedewy
    Salah A. Sheweita
    Mostafa Hasan Mostafa
    Lamia Saeed Kandil
    Indian Journal of Hematology and Blood Transfusion, 2018, 34 : 337 - 337
  • [35] Effect of CYP2C9 and VKORC1 genetic variations on warfarin dose requirements in Indian patients
    Sripriya Natarajan
    Chandrashekhar K. Ponde
    Rajesh M. Rajani
    Farah Jijina
    Roopkumar Gursahani
    Pradnya P. Dhairyawan
    Tester F. Ashavaid
    Pharmacological Reports, 2013, 65 : 1375 - 1382
  • [36] Effect of CYP2C9 and VKORC1 genetic variations on warfarin dose requirements in Indian patients
    Natarajan, Sripriya
    Ponde, Chandrashekhar K.
    Rajani, Rajesh M.
    Jijina, Farah
    Gursahani, Roopkumar
    Dhairyawan, Pradnya P.
    Ashavaid, Tester F.
    PHARMACOLOGICAL REPORTS, 2013, 65 (05) : 1375 - 1382
  • [37] Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin
    Flockhart, David A.
    O'Kane, Dennis
    Williams, Marc S.
    Watson, Michael S.
    Flockhart, David A.
    Gage, Brian
    Gandolfi, Roy
    King, Richard
    Lyon, Elaine
    Nussbaum, Robert
    O'Kane, Dennis
    Schulman, Kevin
    Veenstra, David
    Williams, Marc S.
    Watson, Michael S.
    GENETICS IN MEDICINE, 2008, 10 (02) : 139 - 150
  • [38] Frequency of CYP2C9 and VKORC1 Polymorphisms Affecting Warfarin Metabolism in an Indian Population
    Das, B.
    Chheda, P.
    Khadapkar, R. D.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (06): : 625 - 625
  • [39] Polymorphism of the CYP2C9 and VKORC1 genes: a comment
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    JORNAL VASCULAR BRASILEIRO, 2021, 20
  • [40] Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients
    Nassr Eldin M. A. Shrif
    Hong-Hee Won
    Seung-Tae Lee
    Jun-Hee Park
    Ka-Kyung Kim
    Min-Ji Kim
    Seonwoo Kim
    Soo-Youn Lee
    Chang-Seok Ki
    Ihsan M. Osman
    Enaam A. Rhman
    Ibtisam A. Ali
    M. N. A. Idris
    Jong-Won Kim
    European Journal of Clinical Pharmacology, 2011, 67 : 1119 - 1130
12345